Johnson & Johnson Cash Conversion Cycle 2011-2026 | JNJ

Annual Cash Conversion Cycle Johnson & Johnson

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
88.2	85.5	70.7	257	29	-	70.7	77.4	80.1	79.5	-	62.8	87.1	69.5	53.2

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
257	29	85.4

Quarterly Cash Conversion Cycle Johnson & Johnson

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
120	107	109	111	106	106	104	108	96.1	-	47.5	39.3	65.9	-	76	75.4	39.9	-	97.4	102	77.2	63.7	70.1	70.5	75.7	63.1	77.9	75.8	80.3	61	81.8	65.3	62.2	-	-	-	-	-	-	-	-	-	54.3	51.4	57.2	-	60.8	59.8	60	-	60.5	62.6	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
120	39.3	76.4

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Altimmune ALT	7.85 K	$ 3.41	2.1 %	$ 300 M	USA
Amgen AMGN	217	$ 350.17	0.68 %	$ 188 B	USA
Amphastar Pharmaceuticals AMPH	205	$ 19.57	0.36 %	$ 915 M	USA
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Aytu BioScience AYTU	174	$ 2.64	1.15 %	$ 16.6 M	USA
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-8.96 K	-	-10.17 %	$ 12.2 K	USA
Benitec Biopharma BNTC	141	$ 11.0	0.18 %	$ 453 M	USA
Acorda Therapeutics ACOR	117	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	-1.55 K	-	-0.23 %	$ 916 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Advaxis ADXS	-143 K	-	-9.65 %	$ 45.9 M	USA
Coherus BioSciences CHRS	149	$ 1.58	3.62 %	$ 185 M	USA
Cellectis S.A. CLLS	-839	$ 3.35	0.3 %	$ 116 M	France
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
BioDelivery Sciences International BDSI	340	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Calithera Biosciences CALA	28.8	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.1	-	-	$ 3.74 B	USA
CorMedix CRMD	359	$ 6.29	0.64 %	$ 453 K	USA
CytomX Therapeutics CTMX	12.2	$ 4.41	-1.01 %	$ 608 M	USA
Clovis Oncology CLVS	65.5	-	-7.23 %	$ 13 M	USA
Compugen Ltd. CGEN	-82.7	$ 2.12	1.2 %	$ 198 M	Israel
Denali Therapeutics DNLI	1.89	$ 20.92	3.69 %	$ 3.44 B	USA
Dyadic International DYAI	-128	$ 0.89	-5.85 %	$ 25.6 M	USA
Arbutus Biopharma Corporation ABUS	31.5	$ 4.26	0.47 %	$ 707 M	Canada